CorMedix Inc.
CRMD
$12.08
$0.585.04%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 196.32% | 134.20% | 61.31% | -15.97% | -43.93% |
| Total Depreciation and Amortization | 296.38% | 494.32% | 337.57% | 161.13% | 73.11% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 46.49% | 27.67% | 13.96% | 19.21% | 15.38% |
| Change in Net Operating Assets | -676.02% | -3,681.25% | -1,866.88% | -2,701.31% | -965.27% |
| Cash from Operations | 159.98% | 70.07% | -31.78% | -64.84% | -63.24% |
| Capital Expenditure | 86.62% | 82.69% | 64.62% | -150.81% | -77.65% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -191.74% | 75.05% | 227.56% | 228.76% | 192.13% |
| Cash from Investing | -194.52% | 84.03% | 224.43% | 225.32% | 188.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 160.34% | -31.06% | -52.58% | -74.49% | 131.71% |
| Repurchase of Common Stock | -457.69% | -309.98% | -45.97% | -19.25% | -19.25% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 158.75% | -33.14% | -52.93% | -74.79% | 132.88% |
| Foreign Exchange rate Adjustments | 133.33% | -133.33% | -160.71% | -88.27% | -108.11% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,393.46% | 214.62% | -783.99% | -280.54% | 129.92% |